염현아 기자

Yeom Hyun-a Staff writer, ScienceChosun News Desk

Total articles(452)
Takeda Pharmaceuticals Korea names Kim Mi-seung as head of oncology division
Takeda Pharmaceuticals Korea names Kim Mi-seung as head of oncology division
Takeda Pharmaceuticals Korea announced on the 17th that it has appointed Kim Mi-seung as the new head of its oncology division. The new head, Kim Mi-seung, has over 20 years of experience in marketing, medical affairs, and academic sales in the domestic and international pharmaceutical and medical f...
Menstrual disorders heighten depression risk among adolescents in South Korea
Research results show that women who have experienced menstrual disorders such as dysmenorrhea and premenstrual syndrome are more likely to experience depression. The influence during adolescence was particularly pronounced. The Korea Disease Control and Prevention Agency noted that research finding...
Son Dam-bi gives birth to healthy girl and stores cord blood for future
Gangnam CHA Women's Hospital announced on the 17th that singer and actress Son Dam-bi gave birth to a healthy girl on the 11th. According to Gangnam CHA Women's Hospital, Son stored umbilical cord blood at CHA Hospital's cord blood bank, i-Code, for the healthy future of her baby. Son said, "I reali...
Localizing medical cannabis production in Korea can reduce costs and aid health insurance
The only medical cannabis treatment approved in the country is the epilepsy medication "Epidiolex." Although the Ministry of Food and Drug Safety has permitted special importation upon patient request since 2019, the issue lies in the price. Epidiolex, which is entirely imported from the United Stat...
Trump signs executive order reducing drug prices, boosting biosimilar firms in U.S.
U.S. President Donald Trump signed an executive order favoring generic drugs to reduce the financial burden of healthcare on Americans. The core of the order is to simplify approval procedures and lower barriers to market entry. As a result, expectations are rising that domestic corporations could b...
U.S. Blocks NIH Medical Database Access for Some Countries, Excludes South Korea
The Korea Bio Association noted on the 16th that the National Institutes of Health (NIH) has blocked access to medical databases for certain countries of concern. The countries subject to the access ban include China, Hong Kong, Macau, Russia, Iran, North Korea, Cuba, and Venezuela. Attention is dra...
Patients face barriers to accessing medical cannabis in South Korea, highlighting urgent need for reform
#. 13-year-old Choi was diagnosed with intractable epilepsy known as 'Lennox-Gastaut syndrome' at the age of two. Subsequently, the medical cannabis product 'Epidiolex' from GW Pharmaceuticals in the United Kingdom was introduced in South Korea. Health insurance support was possible, but Choi's moth...
Seoul National University Hospital launches global R&D hub in Boston to boost K-bio
Seoul National University Hospital announced on the 15th that it has opened the 'Seoul National University Hospital Global R&D Hub Center (Boston Office)' in Boston, USA. This opening marks the establishment of the first global base specializing in advanced bio research and technology commercializat...
Raw pet diets raise H5N1 infection risks, experts urge stronger safety measures in Korea
There have been warnings that feeding pets raw diets such as unpasteurized milk or raw meat increases the risk of infection with the highly pathogenic (H5N1) avian influenza virus. The veterinary community pointed out that the safety of raw diets has not been scientifically proven for pets and that ...
Lunit supplies cancer diagnosis AIs to GC i-MED for health screenings
Lunit announced on the 15th that it has entered into a supply contract with GC Biopharma for its chest X-ray image analysis artificial intelligence (AI) ‘Lunit Insight CXR’ and mammography image analysis AI ‘Lunit Insight MMG.’ Under this contract, Lunit Insight AI will be utilized at the Gangnam an...
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10